A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection

Mostrar otras versiones (1)

Broadly neutralizing antibodies (bnAbs) to coronaviruses (CoVs) are valuable in their own right as prophylactic and therapeutic reagents to treat diverse CoVs and, importantly, as templates for rational pan-CoV vaccine design. We recently described a bnAb, CC40.8, from a coronavirus disease 2019 (CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Panpan, Yuan, Meng, Song, Ge, Beutler, Nathan, Shaabani, Namir, Huang, Deli, He, Wan-ting, Zhu, Xueyong, Callaghan, Sean, Yong, Peter, Anzanello, Fabio, Peng, Linghang, Ricketts, James, Parren, Mara, Garcia, Elijah, Rawlings, Stephen A., Smith, Davey M., Nemazee, David, Teijaro, John R., Rogers, Thomas F., Wilson, Ian A., Burton, Dennis R., Andrabi, Raiees
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939767/
https://www.ncbi.nlm.nih.gov/pubmed/35133175
http://dx.doi.org/10.1126/scitranslmed.abi9215

Ejemplares similares

Ejemplares similares